home / stock / axim / axim news

AXIM News and Press, Axim Biotechnologies Inc From 08/24/20

Stock Information
Company Name: Axim Biotechnologies Inc
Stock Symbol: AXIM
Market: OTC
Website: aximbiotech.com
Menu
AXIM AXIM Quote AXIM Short AXIM News AXIM Articles AXIM Message Board
Get AXIM Alerts

News, Short Squeeze, Breakout and More Instantly...
AXIM - AXIM® Biotechnologies Signs Exclusive Licensing, Manufacturing and Distribution Agreement for High Volume Production of the COVID-19 Rapid Neutralizing Antibody Test

SAN DIEGO, Aug. 24, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc.  (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announ...
AXIM - Sapphire Biotech, Subsidiary of AXIM® Biotechnologies, Awarded Prestigious Phase I Small Business Innovation Research Grant by National Cancer Institute

SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announces tha...

AXIM - AXIM® Biotechnologies Applies for FDA Emergency Use Approval (EUA) for High Throughput, Patent-Pending Neutralizing Antibody Diagnostic Test for COVID-19

SAN DIEGO, Aug. 05, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc.  (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announ...

AXIM - 24/7 Market News- U.S. government plows more funds into its existing Moderna contract

DENVER, Colo., July 27, 2020- Moderna (NASDAQ:MRNA) was the weekend’s big Corona winner, as the U.S. government adjusted its existing contract, by increasing funding, by up to $472 million, for a "significantly" larger Phase 3 study of the company's COVID-19 mRNA vaccine candidate (mRNA-1...
AXIM - Making A List Of Penny Stocks Right Now? 4 Spiking This Week

Are These On Your List Of Penny Stocks Right Now? Putting together a good list of penny stocks doesn’t take a whole lot of time. The research certainly can though. Depending on your goals, time frame, and risk tolerance, you can design plenty of lists to fit your strategy. One place t...

AXIM - 24/7 Market News- Venture Biotechs on the move

DENVER, Colo., July 23, 2020- Yesterday’s announcement that the U.S. Department of Health and Human Services agreed to purchase up to 600 million doses of COVID-19 vaccine, from Pfizer (NYSE:PFE) and its development partner BioNTech (NASDAQ:BNTX), is the latest example of why biotech cont...

AXIM - AXIM® Biotechnologies Releases Rapid NeuCovix(TM) Test Results Showing Strong Agreement with COVID-19-Based Neutralization Tests

SAN DIEGO, July 23, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announces the...
AXIM - Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 444

Delta, Kelowna, BC - July 21, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from ...

AXIM - AXIM® Biotechnologies Welcomes Former Secretary of Veterans Affairs Peter O'Rourke to Company's Board of Directors

SAN DIEGO, July 21, 2020 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM® Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today it has welcomed Former Secretary of...

AXIM - Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Unveils World's First COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies and Files Pre-Emergency Use Authorization

SAN DIEGO, July 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply c...
Previous 10 Next 10